Thus, the release into the HL microenvironment of Exo-like microvesicles carrying ADAM10 can result in the shedding of cytokines, including TNFα, which work as a lymphoma growth factor, or soluble molecules, such as sMICA and sCD30, which interfere with host immune response and with antibody immunotherapy. Here, ADAM10 is linked to lymphoma.